MacroGenics

IPO

Developing innovative antibody-based cancer therapeutics

Public · Rockville, United States · Founded 2000 · $100.5M raised

Employees
201–500
Founded
2000
Business Model
B2B
Total Funding
$100.5M
Last Round
$25.0M Extension RoundSep 2008
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 4 investors for this company. The full record is or through the API.

About

MacroGenics is a Rockville, Maryland-based clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. Founded in 2000, the company has built proprietary technology platforms for antibody-drug conjugates (ADCs), bispecific checkpoint antibodies, and next-generation T-cell engagers, and has developed three FDA-approved therapies. MacroGenics maintains strategic collaborations with companies such as Incyte, Gilead, and Sanofi, and operates additional offices in South San Francisco, California.

Summary

MacroGenics is a Biotech company based in Rockville, United States, founded in 2000. It has raised $100.5M in total across 4 rounds, most recently a $25.0M Extension Round in Sep 2008. Investors include Alta Partners, TPG (Growth/Rise) and InterWest Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOOct 2013
$92.0M

Sign up to see all 5 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MacroGenics on Indexed.vc
<a href="https://indexed.vc/companies/macrogenics"><img src="https://indexed.vc/api/badge/company/macrogenics" alt="MacroGenics on Indexed.vc" width="260" height="76" /></a>